Autopsy report · NCT01199783

Application of Daptomycin in MRSA Infected Diabetic Foot in Comparison to Vancomycin Treatment

“Patient number to be enrolled not reachable in prospected time frame, decision to stop the study prematurely was made.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 3 months before it started.
• Ran for about 2 years 5 months before it stopped.
• 1 participant enrolled.
• Results were posted on the registry 10 years 3 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Ruhr University of Bochum

Sponsor type

University, hospital or other

Conditions

Diabetic Foot

Interventions

Daptomycin; Vancomycin

Participants

1

Sites

1

Countries

Germany

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.